HealthWatchlist verdict: a small trial suggests inhaled Damask rose oil may improve PMS symptom scores. Replication and better blinding are needed before calling it an effective treatment.
The main clinical trial
A randomised trial enrolled 66 women with PMS and analysed 64 who completed it. Participants inhaled either 4% Rosa damascena oil or sweet almond oil for five minutes, twice daily during the luteal phase.
The intervention continued for two cycles. The authors reported greater improvement in total PMS scores and several symptom groupings with rose oil.
Why the result is promising, not conclusive
The trial was small and relied on participant-reported symptoms. Rose has a recognisable aroma, while the comparator was not an equivalent active fragrance. Participants may therefore have guessed which treatment they received.
The analysis focused on participants who completed the study. Results can look more favourable when people who withdraw are not included in the main comparison.
One research group and one protocol cannot show how well the result applies to different ages, severities, products or patterns of symptoms.
The wider aromatherapy literature
A systematic review and meta-analysis of eight trials found favourable pooled results for aromatherapy and PMS. Statistical heterogeneity was high, reflecting substantial differences between studies.
The review supports further research but does not erase the weaknesses of individual trials. It also cannot show that rose is superior to other oils or to evidence-based PMS treatments.
Product identity matters
The trial used diluted essential oil of Rosa damascena. Rose absolute, rose water, fragrance oil and products based on other rose species are different preparations. A label saying only “rose scent” is insufficient.
Kew records Rosa damascena as a recognised hybrid name. Botanical identification is part of deciding whether research matches a product.
What replication should improve
A follow-up trial should recruit enough participants to estimate a clinically meaningful difference and include those who withdraw in the analysis. Outcomes and statistical methods should be registered before enrolment begins.
An active aromatic comparator would improve blinding, although perfect scent blinding may remain impossible. Recording treatment preference and guessed allocation would help readers judge the influence of expectation.
Safety and when to seek help
Inhaled fragrance can cause headache, nausea or airway symptoms. Topical oils can irritate or sensitise skin. Do not swallow rose essential oil or apply it neat.
NHS guidance recommends seeking help when PMS affects daily life. Severe depression, suicidal thoughts, very heavy bleeding or disabling pain need timely professional care.
My assessment
Rose oil has a more relevant clinical trial than many PMS aromatherapy claims. The result is encouraging but remains low-certainty because the sample was small, outcomes were subjective and scent blinding was weak.